Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/105518

Beta release

Statistics of Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0700
2024-0800
2024-0900